New cloud of uncertainty for DNA patents, as SCOTUS takes up Myriad
This article was originally published in Scrip
Executive Summary
Are human genes patentable? That’s the question the US Supreme Court has decided it’s time to answer, with the justices revealing late afternoon on 30 November they would take up a case involving certain BRCA gene patents licensed by Myriad Genetics from the University of Utah.